Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Thijssen

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Life Science Alliance|May 9, 2022
Genetic and compound screens uncover factors modulating cancer cell response to indisulamZiva Pogacar, Kelvin Groot, Fleur Jochems, et al.
NPJ Breast Cancer|March 23, 2021
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situMathilde M M Almekinders, Michael Schaapveld, Bram Thijssen, et al.
British Journal of Cancer|June 12, 2024
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)S Lot Aronson, Cédric Walker, Bram Thijssen, et al.
Breast Cancer Research : BCR|October 4, 2023
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancerTessa G Steenbruggen, Denise M Wolf, Michael J Campbell, et al.
Cell Reports. Medicine|November 17, 2022
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancerKatrin J Frank, Antonio Mulero-Sánchez, Alexandra Berninger, et al.
British Journal of Cancer|June 29, 2022
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer riskMathilde M Almekinders, Tycho Bismeijer, Tapsi Kumar, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Life Science Alliance|May 9, 2022
Genetic and compound screens uncover factors modulating cancer cell response to indisulamZiva Pogacar, Kelvin Groot, Fleur Jochems, et al.
NPJ Breast Cancer|March 23, 2021
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situMathilde M M Almekinders, Michael Schaapveld, Bram Thijssen, et al.
British Journal of Cancer|June 12, 2024
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)S Lot Aronson, Cédric Walker, Bram Thijssen, et al.
Breast Cancer Research : BCR|October 4, 2023
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancerTessa G Steenbruggen, Denise M Wolf, Michael J Campbell, et al.
Cell Reports. Medicine|November 17, 2022
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancerKatrin J Frank, Antonio Mulero-Sánchez, Alexandra Berninger, et al.
British Journal of Cancer|June 29, 2022
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer riskMathilde M Almekinders, Tycho Bismeijer, Tapsi Kumar, et al.
Pageof 2